GlycoMimetics Inc

GKO

Company Profile

  • Business description

    GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

  • Contact

    P.O. Box 65
    MonroviaMD21770
    USA

    T: +1 240 243-1201

    E: [email protected].

    https://www.glycomimetics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    26

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,579.9050.100.59%
CAC 407,886.6933.220.42%
DAX 4023,767.4371.840.30%
Dow JONES (US)42,654.74331.990.78%
FTSE 1008,684.5650.810.59%
HKSE23,345.05108.11-0.46%
NASDAQ19,211.1098.780.52%
Nikkei 22537,753.721.79-0.00%
NZX 50 Index12,749.0237.77-0.30%
S&P 5005,958.3841.450.70%
S&P/ASX 2008,343.7046.200.56%
SSE Composite Index3,367.4613.36-0.40%

Market Movers